Literature DB >> 24345823

Changes in matrix metalloproteinase-9 levels during progression of atrial fibrillation.

Mingjiang Li1, Guokang Yang, Bin Xie, Kamesh Babu, Congxin Huang.   

Abstract

OBJECTIVES: To observe levels of matrix metalloproteinase (MMP)-9 and evaluate their significance in various stages of idiopathic atrial fibrillation (AF).
METHODS: Patients with idiopathic AF were recruited into this prospective study and classified into one of three groups according to stage of disease progression: paroxysmal AF; persistent AF; permanent AF. Healthy individuals were enrolled as control subjects. Serum levels of MMP-9 in all four groups were determined using a double-antibody sandwich enzyme-linked immunosorbent assay.
RESULTS: Each AF group included 25 patients; 40 healthy individuals were included as controls. MMP-9 levels in the three AF groups were significantly higher than in the control group: 168.72 ± 25.970, 201.36 ± 31.26 and 253.20 ± 22.99 ng/ml for the paroxysmal, persistent and permanent AF groups respectively, versus 76.80 ± 14.90 ng/ml for the control group. MMP-9 levels increased with idiopathic AF disease progression (P < 0.05).
CONCLUSIONS: An elevated MMP-9 level appears to be associated with a diagnosis of AF. MMP-9 levels appear to increase in relation to the stage of idiopathic AF progression.

Entities:  

Keywords:  Atrial fibrillation; concentration; disease progression; extracellular matrix; matrix metalloproteinase-9; pathological mechanism

Mesh:

Substances:

Year:  2013        PMID: 24345823     DOI: 10.1177/0300060513488514

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  15 in total

1.  The serum matrix metalloproteinase-9 level is an independent predictor of recurrence after ablation of persistent atrial fibrillation.

Authors:  Gang Wu; Shun Wang; Mian Cheng; Bin Peng; Jingjun Liang; He Huang; Xuejun Jiang; Lizhi Zhang; Bo Yang; Yongmei Cha; Hong Jiang; Congxin Huang
Journal:  Clinics (Sao Paulo)       Date:  2016-05       Impact factor: 2.365

Review 2.  Potential Biological Markers of Atrial Fibrillation: A Chance to Prevent Cryptogenic Stroke.

Authors:  István Szegedi; László Szapáry; Péter Csécsei; Zoltán Csanádi; László Csiba
Journal:  Biomed Res Int       Date:  2017-07-13       Impact factor: 3.411

3.  Transcriptome profiling of cancer tissues in Chinese patients with gastric cancer by high-throughput sequencing.

Authors:  Peiying Tian; Chunli Liang
Journal:  Oncol Lett       Date:  2017-12-08       Impact factor: 2.967

4.  1-(5-Bromo-2-hydroxy-4-methoxyphenyl)ethanone [SE1] Inhibits MMP-9 Expression by Regulating NF-κB and MAPKs Signaling Pathways in HT1080 Human Fibrosarcoma Cells.

Authors:  Fang Gong; YuanYuan Zhang; JiaChao Lin; ChengYong Li; ChunXia Zhou; PengZhi Hong; BoMi Ryu; Zhong-Ji Qian
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-05       Impact factor: 2.629

5.  Atrial fibrosis underlying atrial fibrillation (Review).

Authors:  Chang Yi Li; Jing Rui Zhang; Wan Ning Hu; Song Nan Li
Journal:  Int J Mol Med       Date:  2021-01-15       Impact factor: 4.101

6.  MMP9 Rs3918242 Polymorphism Affects Tachycardia-Induced MMP9 Expression in Cultured Atrial-Derived Myocytes but Is Not a Risk Factor for Atrial Fibrillation among the Taiwanese.

Authors:  Fu-Chih Hsiao; Yung-Hsin Yeh; Wei-Jan Chen; Yi-Hsin Chan; Chi-Tai Kuo; Chun-Li Wang; Chi-Jen Chang; Hsin-Yi Tsai; Feng-Chun Tsai; Lung-An Hsu
Journal:  Int J Mol Sci       Date:  2016-04-07       Impact factor: 5.923

7.  Matrix Metalloproteinase-9 Is a Predictive Factor for Systematic Hypertension and Heart Dysfunction in Patients with Obstructive Sleep Apnea Syndrome.

Authors:  Shuhui Wang; Shisheng Li; Bin Wang; Jiajia Liu; Qinglai Tang
Journal:  Biomed Res Int       Date:  2018-03-06       Impact factor: 3.411

Review 8.  Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications.

Authors:  Nicolas Clementy; Eric Piver; Arnaud Bisson; Clémentine Andre; Anne Bernard; Bertrand Pierre; Laurent Fauchier; Dominique Babuty
Journal:  Int J Mol Sci       Date:  2018-03-25       Impact factor: 5.923

9.  Synthesis, radiosynthesis, in vitro and first in vivo evaluation of a new matrix metalloproteinase inhibitor based on γ-fluorinated α-sulfonylaminohydroxamic acid.

Authors:  Verena Hugenberg; Malte Behrends; Stefan Wagner; Sven Hermann; Michael Schäfers; Hartmuth C Kolb; Katrin Szardenings; Joseph C Walsh; Luis F Gomez; Klaus Kopka; Günter Haufe
Journal:  EJNMMI Radiopharm Chem       Date:  2018-07-27

10.  Atrial Structural Remodeling Gene Variants in Patients with Atrial Fibrillation.

Authors:  Rosa Doñate Puertas; Gilles Millat; Isabelle Ernens; Vincent Gache; Samuel Chauveau; Elodie Morel; Emilie Christin; Nathalie Couturier; Yvan Devaux; Philippe Chevalier
Journal:  Biomed Res Int       Date:  2018-09-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.